Microbial Conversion Products of Leptomycin B
Leptomycin B (LMB), a secondary metabolite produced by Streptomyces sp. strain ATS 1287, with known antifungal and antitumor effects, inhibits the nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 regulatory protein Rev and exhibits significant antiproliferative activity. S...
שמור ב:
| הוצא לאור ב: | Appl Environ Microbiol |
|---|---|
| Principais autores: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology (ASM)
1998
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC106107/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9464413/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aem.64.2.714-720.1998 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|